Stiefel Sues Cobrek, Perrigo Over Generic Acne Drug
Stiefel Laboratories Inc. has sued Cobrek Pharmaceuticals Inc. and its partner Perrigo Co. over their plans to develop a generic version of the acne treatment Evoclin, which Stiefel claims would infringe...To view the full article, register now.
Already a subscriber? Click here to view full article